4th Quarter - Report

W STRATEGIES, LLC for MEDTRONIC, INC.

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 6: 21st Century Cures Act, including potential changes to post market medical device registries and Medicaid reimbursement for DMEPOS. James Zadroga 9/11 Health and Compensation Reauthorization as it relates to offsets impacting DMEPOS in Medicaid.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6 (114th)

Medicare/Medicaid MMM

H.R. 1427: Medicare CGM Access Act of 2014.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1427 (114th)

Taxation/Internal Revenue Code TAX

Provided continuing support for Medtronic acquisition of Covidien, including potential legislation on federal contracting limitations and other tax policy proposals. Issues related to corporate tax reform, including international tax issues. P.L. 114-113: "Consolidated Appropriations Act" with respect to the Protecting Americans from Tax Hikes Act and provisions related to delay in the medical device tax. H.R. 160: Protect Medical Innovation Act of 2016.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 160 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.